ZyVersa director Min Chul Park resigns from board, committee roles
ZVSA•Director resigns effective immediately
ZyVersa Therapeutics director Min Chul Park resigned July 8, 2026, stepping down from the board and two board committees, effective immediately.
Company weighs cost-cutting and capital-raising options
The company began exploring cost-cutting measures while it seeks to raise capital, including potential asset sales, headcount reductions, or other strategic alternatives.
